title: Leptin increases growth of primary ossification centers in fetal mice.
abstract: The effect of peripheral leptin on fetal primary ossification centers during the early phases of bone histogenesis was investigated by administration of leptin to pregnant mice. Fourteen pregnant mice were divided into two groups. The treated pregnant group was subcutaneously injected in the intrascapular region with supraphysiologic doses (2 mg kg(-1)) of leptin (Vinci Biochem, Firenze, Italy) in a volume of 0.1 mL per 10 g body weight, at the 7th, 9th and 11th day of gestation. The control group was treated with physiological solution in the same manner and same times as the treated group. The new-born mice were killed 1 day after birth and the primary ossification centers were stained with Alizarin Red S after diaphanizing the soft tissues in 1% potassium hydroxide. The development of both endochondral and intramembranous ossification centers was morphometrically analysed in long bones. The results showed that the ossification centers of mice born by mothers treated with leptin grow more rapidly in both length and cross-sectional area compared with mice born by the untreated mothers. As the development of long bones depends on endochondral ossification occurring at proximal and distal epiphyseal plates as well as on intramembranous ossification along the periosteal surface, it appears that leptin activates the differentiation and proliferation of both chondrocytes and osteoblasts. The role of leptin as a growth factor of cartilage and bone is discussed in the light of the data reported in the literature.
authors.affiliation: Department of Anatomy and Histology - University of Modena and Reggio Emilia, Modena, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Bertoni
authors.forename: Marzia
authors.initials: M
authors.lastname: Ferretti
authors.forename: Francesco
authors.initials: F
authors.lastname: Cavani
authors.forename: Manuela
authors.initials: M
authors.lastname: Zavatti
authors.forename: Elisa
authors.initials: E
authors.lastname: Resca
authors.forename: Augusta
authors.initials: A
authors.lastname: Benelli
authors.forename: Carla
authors.initials: C
authors.lastname: Palumbo
mesh_terms: D000818:Animals; D001842:Bone and Bones / Q000187:drug effects / Q000196:embryology*; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D005260:Female; D020738:Leptin / Q000494:pharmacology*; D008431:Maternal-Fetal Exchange / Q000502:physiology; D051379:Mice; D038081:Organogenesis / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects* / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
chemical_list: D020738:Leptin
references.citation: Bone. 2005 Nov;37(5):607-21
references.pmid: 16039170
references.citation: J Endocrinol. 2002 Nov;175(2):405-15
references.pmid: 12429038
references.citation: J Bone Miner Res. 2002 Jun;17(6):1034-43
references.pmid: 12054158
references.citation: Endocrinology. 1999 Apr;140(4):1630-8
references.pmid: 10098497
references.citation: Cell. 2000 Jan 21;100(2):197-207
references.pmid: 10660043
references.citation: Peptides. 2006 Jun;27(6):1426-33
references.pmid: 16321456
references.citation: Biochem Biophys Res Commun. 1997 Nov 26;240(3):798-802
references.pmid: 9398648
references.citation: Cell. 2002 Nov 1;111(3):305-17
references.pmid: 12419242
references.citation: Endocrinology. 2005 Aug;146(8):3652-9
references.pmid: 15845621
references.citation: Annu Rev Physiol. 2000;62:413-37
references.pmid: 10845097
references.citation: J Clin Endocrinol Metab. 1997 Oct;82(10):3239-45
references.pmid: 9329346
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14564-8
references.pmid: 8962092
references.citation: Biochem Biophys Res Commun. 2001 Sep 14;287(1):190-7
references.pmid: 11549273
references.citation: Orthod Craniofac Res. 2003 Nov;6(4):233-41
references.pmid: 14606527
references.citation: Endocrinology. 2003 Jul;144(7):3024-30
references.pmid: 12810558
references.citation: Life Sci. 1998;63(16):1387-95
references.pmid: 9952284
references.citation: J Musculoskelet Neuronal Interact. 2000 Dec;1(2):133-6
references.pmid: 15758506
references.citation: Endocrinology. 2001 Aug;142(8):3546-53
references.pmid: 11459801
references.citation: J Bone Miner Res. 2002 Feb;17(2):200-9
references.pmid: 11811550
references.citation: J Histochem Cytochem. 2002 Feb;50(2):159-69
references.pmid: 11799135
references.citation: Science. 1998 Sep 11;281(5383):1683-6
references.pmid: 9733517
references.citation: Nature. 1998 Oct 22;395(6704):763-70
references.pmid: 9796811
references.citation: J Anat. 2004 Oct;205(4):291-6
references.pmid: 15447688
references.citation: Nature. 1994 Dec 1;372(6505):425-32
references.pmid: 7984236
references.citation: Regul Pept. 2000 Aug 25;92(1-3):73-8
references.pmid: 11024568
references.citation: Horm Metab Res. 1996 Dec;28(12):659-63
references.pmid: 9013737
references.citation: J Bone Miner Res. 2001 Aug;16(8):1426-33
references.pmid: 11499865
references.citation: Endocrinology. 1997 Feb;138(2):797-804
references.pmid: 9003017
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20529-33
references.pmid: 19074282
references.citation: J Clin Endocrinol Metab. 2000 May;85(5):1997-9
references.pmid: 10843187
references.citation: Physiol Res. 2008;57 Suppl 1:S143-S151
references.pmid: 18271682